J Suda

779 total citations
27 papers, 640 citations indexed

About

J Suda is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, J Suda has authored 27 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and 6 papers in Oncology. Recurrent topics in J Suda's work include Hematopoietic Stem Cell Transplantation (5 papers), Cancer Cells and Metastasis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). J Suda is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Cancer Cells and Metastasis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). J Suda collaborates with scholars based in Japan, Slovakia and United States. J Suda's co-authors include Toshio Suda, Minetaro Ogawa, Yasusada Miura, Hiromitsu Nakauchi, T Sudo, Seiji Okada, Mitsuoki Eguchi, Masaki Saito, Yuji Yamaguchi and J N Ihle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.

In The Last Decade

J Suda

25 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Suda Japan 14 277 255 220 137 82 27 640
T Nakahata Japan 13 278 1.0× 309 1.2× 198 0.9× 106 0.8× 87 1.1× 30 634
JM Kerst Netherlands 9 218 0.8× 292 1.1× 148 0.7× 146 1.1× 86 1.0× 11 685
AW Wognum Netherlands 13 333 1.2× 196 0.8× 161 0.7× 127 0.9× 74 0.9× 22 559
Saul J. Sharkis United States 6 384 1.4× 183 0.7× 283 1.3× 178 1.3× 173 2.1× 6 703
T M Dexter United Kingdom 15 399 1.4× 241 0.9× 225 1.0× 205 1.5× 227 2.8× 24 822
P. M. Lansdorp Canada 12 563 2.0× 191 0.7× 222 1.0× 93 0.7× 180 2.2× 13 827
AG Leary United States 9 504 1.8× 360 1.4× 190 0.9× 240 1.8× 162 2.0× 12 882
IC Slaper-Cortenbach Netherlands 7 313 1.1× 308 1.2× 130 0.6× 122 0.9× 63 0.8× 11 638
R.S. Hill United States 11 570 2.1× 238 0.9× 174 0.8× 185 1.4× 168 2.0× 20 822
CA Sieff United States 16 471 1.7× 394 1.5× 166 0.8× 203 1.5× 146 1.8× 25 906

Countries citing papers authored by J Suda

Since Specialization
Citations

This map shows the geographic impact of J Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Suda more than expected).

Fields of papers citing papers by J Suda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Suda. The network helps show where J Suda may publish in the future.

Co-authorship network of co-authors of J Suda

This figure shows the co-authorship network connecting the top 25 collaborators of J Suda. A scholar is included among the top collaborators of J Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Suda. J Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Akihiko, Saeko Nomura, Seiichi Hirota, et al.. (1995). Enhanced expression of CD34 messenger RNA by developing endothelial cells of mice.. PubMed. 72(5). 532–8. 50 indexed citations
2.
Tsunoda, J, Seiji Okada, J Suda, et al.. (1991). In vivo stem cell function of interleukin-3-induced blast cells. Blood. 78(2). 318–322. 17 indexed citations
3.
Gunji, Yuji, T Sudo, J Suda, et al.. (1991). Support of early B-cell differentiation in mouse fetal liver by stromal cells and interleukin-7. Blood. 77(12). 2612–2617. 5 indexed citations
4.
Tanaka, Toshinori, Toshio Suda, J Suda, et al.. (1991). Stimulatory effects of granulocyte colony-stimulating factor on colony- forming units-spleen (CFU-S) differentiation and pre-CFU-S proliferation in mice. Blood. 77(12). 2597–2602. 14 indexed citations
5.
Tsunoda, J, Seiji Okada, J Suda, et al.. (1991). In vivo stem cell function of interleukin-3-induced blast cells. Blood. 78(2). 318–322. 12 indexed citations
6.
Yamaguchi, Yuji, Toshio Suda, J Suda, et al.. (1990). Analysis of eosinophil-predominant colonies formed by human hemopoietic precursor cells in the presence of purified interleukin-5. 53(4). 688–698. 2 indexed citations
7.
Eguchi, Mitsuoki, et al.. (1989). Lectins for electron microscopic distinction of eosinophils from other blood cells.. Journal of Histochemistry & Cytochemistry. 37(5). 743–749. 6 indexed citations
8.
Suda, Toshio, Seiji Okada, J Suda, et al.. (1989). A stimulatory effect of recombinant murine interleukin-7 (IL-7) on B- cell colony formation and an inhibitory effect of IL-1 alpha. Blood. 74(6). 1936–1941. 65 indexed citations
9.
Eguchi, Mitsuoki, J Suda, Kenichi Sugita, Toshio Suda, & Toshiharu Furukawa. (1989). Cultured human basophils with ultrastructural and ultracytochemical features of mast cells. European Journal Of Haematology. 42(1). 81–89. 5 indexed citations
10.
Minato, Nagahiro, Masakazu Hattori, T Sudo, et al.. (1988). Differentiation in vitro of T3+ large granular lymphocytes with characteristic cytotoxic activity from an isolated hematopoietic progenitor colony.. The Journal of Experimental Medicine. 167(3). 762–776. 15 indexed citations
11.
Suda, Toshio, Misa Ohno, J Suda, et al.. (1988). Transfection of IL-3 gene to a factor-dependent murine myeloid cell line (FDC-P2).. PubMed. 51(8). 1498–504. 1 indexed citations
12.
Hara, Kenji, Toshio Suda, J Suda, et al.. (1988). Bipotential murine hemopoietic cell line (NFS-60) that is responsive to IL-3, GM-CSF, G-CSF, and erythropoietin.. PubMed. 16(4). 256–61. 47 indexed citations
13.
Suda, Toshio, Yuji Yamaguchi, J Suda, et al.. (1988). Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors.. PubMed. 16(11). 891–5. 55 indexed citations
14.
Sato, Yuko, Toshio Suda, J Suda, Masaki Saito, & Yasusada Miura. (1987). Erythroid- and myeloid-lineage involvement in chronic myelomonocytic leukemia.. PubMed. 15(4). 316–22. 4 indexed citations
15.
Kajigaya, Sachiko, Toshio Suda, J Suda, et al.. (1986). A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells.. The Journal of Experimental Medicine. 164(4). 1102–1113. 15 indexed citations
16.
Suda, J, Toshio Suda, Keiichi Kubota, et al.. (1986). Purified interleukin-3 and erythropoietin support the terminal differentiation of hemopoietic progenitors in serum-free culture. Blood. 67(4). 1002–1006. 36 indexed citations
17.
Ogawa, Makoto, Toshio Suda, & J Suda. (1984). Differentiation and proliferative kinetics of hemopoietic stem cells in culture.. PubMed. 148. 35–43. 2 indexed citations
18.
Suda, Toshio, J Suda, & Minetaro Ogawa. (1984). Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors.. Proceedings of the National Academy of Sciences. 81(8). 2520–2524. 176 indexed citations
19.
Placek, V., J. Sevc, J Suda, & T. Trnovec. (1973). Histologic types of lung cancer at different exposure to radon daughters. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 30(8). 1110–1; author reply 1110. 1 indexed citations
20.
Suda, J. (1965). [Follow-up status after meningeal tuberculosis].. PubMed. 113(12). 692–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026